G1 Therapeutics SG&A Expense (Quarterly) Analysis

G1 Therapeutics Inc (GTHX)

4.49 +0.05 (+1.13%) USD | NASDAQ | May 03, 16:00

4.58 +0.09 (+2.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	15.17M
September 30, 2023	16.78M
June 30, 2023	17.43M
March 31, 2023	21.75M
December 31, 2022	23.56M
September 30, 2022	24.43M
June 30, 2022	25.72M
March 31, 2022	26.71M
December 31, 2021	23.22M
September 30, 2021	24.27M
June 30, 2021	25.24M
March 31, 2021	22.97M
December 31, 2020	24.26M
September 30, 2020	18.41M
June 30, 2020	14.43M
March 31, 2020	11.39M

Date	Value
December 31, 2019	12.06M
September 30, 2019	11.08M
June 30, 2019	9.094M
March 31, 2019	7.801M
December 31, 2018	7.008M
September 30, 2018	4.949M
June 30, 2018	3.268M
March 31, 2018	3.378M
December 31, 2017	2.206M
September 30, 2017	1.875M
June 30, 2017	1.712M
March 31, 2017	1.294M
December 31, 2016	1.261M
September 30, 2016	0.918M
June 30, 2016	0.975M
March 31, 2016	2.075M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

9.094M

Minimum

Jun 2019

26.71M

Maximum

Mar 2022

19.37M

Average

21.75M

Median

Mar 2023

SG&A Expense (Quarterly) Benchmarks